Sabrina Dunbar | executive |
Katherine Stueland | executive |
Kevin Feeley | executive |
Tycho Peterson | analyst |
William Bonello | analyst |
Mark Massaro | analyst |
Daniel Brennan | analyst |
Matthew Sykes | analyst |
Good day, and thank you for standing by. Welcome to the GeneDx Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to Sabrina Dunbar, Investor Relations. Please go ahead.
Thank you, operator, and thank you to everyone for joining us today.